Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRC2.L Regulatory News (RC2)

  • There is currently no data for RC2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing

12 Dec 2007 15:45

Reconstruction Capital II Ltd12 December 2007 Reconstruction Capital II Limited (the "Company") 12 December 2007 Results of Placing The Board of the Company is pleased to announce the completion of the Company'sthird round of fund raising (the "Fundraising") which raised a total of €73.4million, upon the issue of 47,641,629 new ordinary shares at €1.54 per share. Application has been made for the 47,641,629 new ordinary shares to be admittedto trading on AIM and this is expected to take place on 19 December 2007. As aresult of the Fundraising, the Company will have 112,681,054 ordinary shares inissue. As a result of the Fundraising, the following information is required to bedisclosed in accordance with Rule 17 of the AIM Rules for Companies (the "AIMRules"): Directors Shareholdings Mr. Dirk Van den Broeck has subscribed for 745,100 ordinary shares. Followingthis subscription, Mr Van den Broek holds 1,490,200 ordinary shares in theCompany representing 1.32% of the Company's enlarged issued share capital. Mr Ion Florescu has subscribed for 200,000 ordinary shares. Following thissubscription, Mr Florescu holds 400,100 ordinary shares in the Companyrepresenting 0.36% of the Company's enlarged issued share capital. Mr Markus Winkler has subscribed for 150,000 ordinary shares. Following thissubscription, Mr Winkler holds 400,000 ordinary shares in the Companyrepresenting 0.35% of the Company's enlarged issued share capital. The Company is aware that the following shareholders subscribed in theFundraising: UBS Fund Services (Cayman) Limited has subscribed for 6,077,320 ordinary sharesrepresenting 12.8% of the new ordinary shares issued in the Fundraising. Sis Segaintersettle AG has subscribed for 6,490,220 ordinary shares representing13.6% of the new ordinary shares issued in the Fundraising. About Reconstruction Capital Limited Listed on the London Stock Exchange AIM market, RC2 is a closed-ended companycreated to invest in private and listed equity securities and fixed-incomesecurities, including convertible and other mezzanine instruments, primarily inRomania and Bulgaria. Under its Private Equity Programme, RC2 invests in significant or controllingstakes in a number of companies, primarily in Romania, Bulgaria and neighboringcountries. RC2 invests in investee companies where it believes the investmentadviser can add value by implementing operational and/or financial restructuringover a three to five-year horizon. Under RC2's Trading Programme, the Company invests in undervalued equitysecurities, initial public offerings (IPOs) of newly privatized companies andfixed-income securities. NEC Romania is RC2's investment adviser for its Private Equity Programme and NECLondon is the investment manager for its Trading Programme. More information about the Company can be found onwww.reconstructioncapital2.com. For further information, please contact: Reconstruction Capital II LimitedIon FlorescuTel: +44 (0) 7767 477192 LCF Edmond de Rothschild Securities (Broker)Hiroshi Funaki / Claire HeathfieldTel: +44 (0) 20 7845 5960 Grant Thornton Corporate Finance (Nominated Adviser)Philip SecrettTel: +44 (0) 20 7383 5100 END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Aug 20144:06 pmRNSNet Asset Value and Monthly Report
26th Aug 20149:34 amRNSQuarterly Report
22nd Aug 20147:00 amRNSInterim Results
25th Jul 20144:39 pmRNSNet Asset Value
7th Jul 20141:30 pmRNSConvertible Loan Update and Bridge Loan Extension
3rd Jul 20149:38 amRNSDirector Shareholding
30th Jun 20144:55 pmRNSNet Asset Value and Monthly Report
20th Jun 201412:07 pmRNSDirector Shareholding
18th Jun 20147:00 amRNSAnnual Results for 31 December 2013
2nd Jun 20145:05 pmRNSMonthly Report and Net Asset Value
2nd Jun 20145:00 pmRNSQuarterly Report
29th Apr 201410:45 amRNSNet Asset Value(s)
28th Apr 201410:37 amRNSDirector/PDMR Shareholding
17th Apr 20144:17 pmRNSNet Asset Value & Monthly Report
11th Apr 201410:50 amRNSNet Asset Value and Monthly Report
9th Apr 201411:49 amRNSDirector Shareholding
24th Mar 201411:39 amRNSQuarterly Report
13th Mar 20144:36 pmRNSNew Valuations of Private Equity Positions
24th Feb 20141:39 pmRNSDirector Shareholding
19th Feb 20145:40 pmRNSInvestment update
20th Dec 20132:29 pmRNSNet Asset Value and Monthly Report
13th Dec 201312:03 pmRNSDirector Shareholding Replacement
13th Dec 20138:28 amRNSDirector Shareholding
10th Dec 20139:43 amRNSDirector Shareholding
4th Dec 201310:48 amRNSDirector Shareholding
27th Nov 201310:00 amRNSDirector Shareholding
27th Nov 20139:56 amRNSNet Asset Value and Monthly Report
26th Nov 20139:24 amRNSResignation of Director
18th Nov 201310:14 amRNSQuarterly Report
18th Oct 201311:18 amRNSNet Asset Value
1st Oct 201310:04 amRNSNet Asset Value and Monthly Report
16th Sep 20134:45 pmRNSDirector Shareholding
4th Sep 20134:22 pmRNSInterim results
23rd Aug 20138:38 amRNSNet Asset Value and Monthly Report
9th Aug 20135:36 pmRNSQuarterly Report
29th Jul 20134:42 pmRNSNet Asset Value(s)
9th Jul 201311:48 amRNSDirector Shareholding
8th Jul 20139:22 amRNSDirector Shareholding
2nd Jul 20131:45 pmRNSNet Asset Value
28th Jun 20137:00 amRNSAnnual Results for 31 December 2012
24th Jun 20132:32 pmRNSNew Valuations of Private Equity Positions
17th May 20135:31 pmRNSNet Asset Value and Portfolio Update
30th Apr 20131:37 pmRNSNet Asset Value and Quarterly Report
12th Apr 20132:30 pmRNSInvestment in Orgachim
4th Apr 20137:00 amRNSNet Asset Value and Monthly Report
6th Mar 20137:50 amRNSNet Asset Value(s)
26th Feb 201310:09 amRNSQuarterly Report
4th Feb 201310:34 amRNSNet Asset Value
21st Dec 20122:44 pmRNSNet Asset Value and Monthly Report
14th Dec 20123:20 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.